Tilray Brands, Inc. TLRY
2.61 USD -0.04 (-1.51%)
At closeNov 11, 2026, 7:55 PM EST
2.60 -0.01 -0.24%
After hours · Nov 11, 7:55 PM ET
2.50 Day range 2.69
2.49 52-week range 15.70
- YTD
- -71.10%
- 1 year
- -79.77%
News
globenewswire.com Whiskey You Won't Find on Shelves: Breckenridge Distillery Launches the 2 Mile High Whiskey Club A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings, Tastings and Behind-The-Scenes Access A Fresh Way to Experience Breckenridge Distillery Through Special Bottlings,…
fool.com Does Marijuana Rescheduling Really Help Tilray's Stock? Rescheduling marijuana to a lower level makes the substance easier to research and results in lower tax bills for companies. Tilray, however, is a Canadian producer and won't directly see any…
fool.com Tilray Raises Its Guidance for the Year. Is the Stock Finally Headed on the Right Track? Tilray is consolidating its operations in Canada to simplify its business and achieve cost savings. The company announced new guidance for adjusted EBITDA that is slightly higher at the low end than…
zacks.com Tilray Brands, Inc. (TLRY) is Attracting Investor Attention: Here is What You Should Know Zacks.com users have recently been watching Tilray Brands (TLRY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
benzinga.com Tilray Stock Rises As Cannabis Giant Raises EBITDA Outlook, Targets Restructuring Across Canada Tilray raises FY2027 EBITDA guidance to $70M-$75M and restructures Canadian cannabis operations, targeting $10M in annual savings.
benzinga.com Tilray Brands Plans To Consolidate Canadian Cannabis Operations, Transitioning Cultivation And Pre-Roll Production From Foss Facility In Fenwick, Ontario To Masson, Quebec And Cayuga, Ontario Facilities Consolidation of Foss Cultivation and Pre-roll Production into Optimized Masson and Cayuga Facilities Expected to Generate Approximately US$10 Million in Annualized Cost SavingsHigher Cultivation…
globenewswire.com Tilray Brands Announces Strategy to Strengthen Canadian Cannabis Operations and Drive Profitable Growth Consolidation of Foss Cultivation and Pre-roll Production into Optimized Masson and Cayuga Facilities Expected to Generate Approximately US$10 Million in Annualized Cost Savings Higher Cultivation…
fool.com Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing Tilray Brands has shifted from a marijuana company to a global brand manager across marijuana, beverages, and wellness. The company's fiscal first quarter 2027 earnings highlight just how much the…
fool.com Tilray Just Posted Record Quarterly Revenue of $257 Million. So Why Did Its Cannabis Sales Shrink? Tilray reported record quarterly revenue of $257.1 million. Cannabis revenue declined 13% despite strong international growth.
fool.com Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis Canopy Growth (CGC -4.34%) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.- benzinga.com Tilray Brands Targets $20M In Annualized Cost Savings Through FY28; Plans Disposal Of Several Brewing And Warehouse Facilities; Reaffirms FY27 Adjusted EBITDA Guidance Of $68M-$75M Successfully Completed Consolidation of U.S. Brewing Footprint from 10 Facilities to SixIdentifying Further Opportunities to Reduce Complexity, Improve Brewery Utilization and Strengthen…
globenewswire.com Tilray Brands Announces Next Phase of Beverage Transformation Successfully Completed Consolidation of U.S. Brewing Footprint from 10 Facilities to Six Identifying Further Opportunities to Reduce Complexity, Improve Brewery Utilization and Strengthen Margins…
fool.com Down 70% in 2026, Has Tilray's Stock Finally Bottomed Out? Tilray's low valuation may be enticing to investors as its market cap is just $400 million. The business, however, struggles to grow organically on a consistent basis.
fool.com Tilray Now Sells More Beer Than Cannabis. Here's Why That Might Be Good News for Investors. Tilray started out as a pure-play marijuana company. The company has since decided to shift toward a consumer staples approach, selling branded products beyond pot.
globenewswire.com Blue Point Brewing Co.'s Legendary Cask Ales Festival Returns to Patchogue with 100+ Limited-Release Brews PATCHOGUE, N.Y., Oct. 22, 2026 (GLOBE NEWSWIRE) -- One of Long Island's longest-running craft beer celebrations is returning to Main Street.
globenewswire.com West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers ELLON, Scotland and LONDON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- BrewDog , a leader in U.K. craft beer and one of the world's most recognised beer brands, owned by Tilray Brands, Inc. (NASDAQ: TLRY;…
benzinga.com Tilray’s Q1 Results Show A Company Transformed Tilray Brands, Inc. (NASDAQ:TLRY) opened fiscal 2027 with the strongest first quarter in its history, reporting record revenue of $257.1 million, up 23% from a year ago. Gross profit set a…
defenseworld.net Tilray Brands (TSE:TLRY) Sets New 52-Week Low – Here’s Why Tilray Brands, Inc. (TSE: TLRY - Get Free Report)'s share price hit a new 52-week low during mid-day trading on Wednesday. The stock traded as low as C$4.61 and last traded at C$4.64, with a volume…
fool.com Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026? Canopy Growth maintains a strategic focus on premium cannabis products and European medical distribution. Tilray Brands has expanded into the craft beverage and wellness markets to diversify its…
globenewswire.com SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia Crack Open the Good Times: Fans 21+ Can Scan the SweetWater QR Code in or Enter Online for a Shot at a Night Out at Georgia Theatre, The Eastern, Variety Playhouse, or Terminal West Crack Open the…
benzinga.com Tilray Brands’ Unit Tilray Medical Secures Key Regulatory Approval For In-House Testing At Portugal Facility Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray Brands, Inc. ("Tilray") (NASDAQ:TLRY, TSX:TLRY), today…
globenewswire.com Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets CANTANHEDE, Portugal, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a global leader in medical cannabis research, cultivation, production, products and distribution and a division of Tilray…
seekingalpha.com BrewDog Acquisition Boosts Tilray's Q1 Performance Tilray reported Q1-2027 financial results last week with increasing revenue from its BrewDog operations; Cannabis revenue decreased. The company expects its new beer assets along with its…
seekingalpha.com Tilray Q1: Not Looking Good, Remains A 'Hold' Tilray reported disappointing fiscal Q1 results, missing revenue estimates despite management highlighting record sales. TLRY's revenue growth was driven solely by the BrewDog acquisition; core…
fool.com 3 Huge Red Flags From Tilray's Q1 Earnings Report Tilray's cash burn continues to be a big problem for investors. The business has been growing through acquisitions, and while that can boost the top line, it can also lead to significantly higher…
benzinga.com Canaccord Genuity Maintains Hold on Tilray Brands, Lowers Price Target to $4 Canaccord Genuity analyst Kenric Tyghe maintains Tilray Brands (NASDAQ:TLRY) with a Hold and lowers the price target from $4.5 to $4.
benzinga.com Tilray Brands Q1 2027 Earnings Call Transcript Tilray Brands (NASDAQ:TLRY) reported first-quarter financial results on Thursday. The transcript from the company's first-quarter earnings call has been provided below. Benzinga APIs provide…
benzinga.com Earnings Scheduled For October 8, 2026 Companies Reporting Before The Bell • Tilray Brands (NASDAQ:TLRY) is likely to report quarterly loss at $0.15 per share on revenue of $266.42 million. • Helen Of Troy (NASDAQ:HELE) is projected to…- benzinga.com Tilray Brands Q1 Adj. EPS $(0.02) Beats $(0.20) Estimate, Sales $257.147M Miss $267.813M Estimate Tilray Brands (NASDAQ:TLRY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.20) by 90 percent. The company reported quarterly sales of $257.147 million…
benzinga.com Tilray Brands Q1 Adj. EPS $(0.02) Beats $(0.20) Estimate, Sales $257.147M Miss $267.464M Estimate Tilray Brands (TSX:TLRY) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.20) by 90 percent. The company reported quarterly sales of $257.147 million…
benzinga.com PepsiCo, Levi Strauss And 3 Stocks To Watch Heading Into Thursday Stocks in focus: Applied Digital beat Q1 estimates; Levi posted mixed results. Investors await earnings from Helen of Troy, PepsiCo and Tilray.
benzinga.com Dow Falls Over 300 Points As Treasury Yields Surge: Investor Sentiment Weakens, Fear & Greed Index Remains In ‘Neutral’ Zone Market sentiment slipped but stayed neutral as U.S. stocks fell amid rising Treasury yields; mortgage applications declined for a fifth week.
benzinga.com Stock Market: Will S&P 500 Open Up or Down Today? Will S&P 500 open higher? Polymarket odds sit at 52% as Wall Street weighs 5.35% Treasury yields, potential Iran strikes, and Pepsi earnings.
benzinga.com PepsiCo Could Swing $6.46 Billion In Value After Earnings Earnings season is set to bring heightened volatility, with PepsiCo, Constellation Brands, Delta Air Lines, Applied Digital and Tilray Brands facing potentially sharp post-earnings moves as options…- benzinga.com 'DEA Judge Pauses Marijuana Rescheduling Hearing As Opponents Highlight Government Report Detailing ‘Gaps’ In Federal Processes'- Marijuana Moment https://www.marijuanamoment.net/dea-judge-pauses-marijuana-rescheduling-hearing-as-opponents-highlight-government-report-detailing-gaps-in-federal-processes/
- benzinga.com Tilray Brands Launches Major Expansion Of Its Global Cannabis Cultivation Capacity To Meet Accelerating International Medical Cannabis Demand Tilray has increased annual cultivation capacity at its Quebec facility by 30 metric tonnes, materially increasing inventory for the Quebec market while adding supply for Europe, Australia and other…
benzinga.com 6 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Tilray Brands (TLRY) Stock Is Trending: Here's What You Should Know Tilray Brands shares jumped 2.23% after hours as quarterly revenue beat estimates, despite earnings per share missing expectations.- benzinga.com Tilray Brands Q4 Adj. EPS $0.05 Beats $(0.01) Estimate, Sales $281.714M Beat $246.377M Estimate Tilray Brands (TSX:TLRY) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.01) by 600 percent. This is a 75 percent decrease over earnings of $0.20 per…
benzinga.com TD Cowen Maintains Buy on Tilray Brands, Lowers Price Target to $5 TD Cowen analyst Robert Moskow maintains Tilray Brands (NASDAQ:TLRY) with a Buy and lowers the price target from $7 to $5.- benzinga.com Tilray Medical Rolls Out Its First Medical Cannabis Product In Panama Tilray Medical, a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) and a leading global medical cannabis company, today announced the commercial launch of its first medical cannabis product in…
benzinga.com Tilray Brands To Acquire HelloMD Corporation; Financial Terms Not Disclosed Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) ("Tilray"), a global leader in medical cannabis, today announced the acquisition of HelloMD Corporation, a digital healthcare and patient engagement…
benzinga.com Trulieve Makes History As First US Cannabis Stock On NYSE https://www.benzinga.com/markets/equities/26/06/53113507/trump-says-iran-took-too-long-and-will-pay-the-price-markets-already-are- benzinga.com Tilray Launches ARX, Its First Premium Medical Cannabis Brand Developed And Cultivated In Germany The introduction of ARX marks a significant step forward in the quality of medical cannabis available in Germany and reflects more than two years of development at the Aphria RX facility in…
- benzinga.com 'White House Pushes Congress To Keep Hemp CBD Products Legal By Amending Broad Ban That's Set To Take Effect Later This Year' - Marijuana Moment https://www.marijuanamoment.net/white-house-pushes-congress-to-keep-hemp-cbd-products-legal-by-amending-broad-ban-thats-set-to-take-effect-later-this-year/
benzinga.com "Marijuana Components Have 'Consistent' Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows" - Marijuana Moment https://www.marijuanamoment.net/marijuana-components-have-consistent-anti-tumor-effec
benzinga.com Why Akanda Stock Is Surging Wednesday? Akanda Corp. (NASDAQ: AKAN) stock surges over 50% Wednesday. Learn how DOJ regulatory shifts and low float dynamics are driving the rally.
benzinga.com Akanda Shares Soar As Cannabis Stocks Rise On US Policy Change Akanda stock surges as U.S. moves to reclassify marijuana, lifting cannabis stocks and fueling strong momentum.
benzinga.com Tilray Smells Opportunity After Historic Cannabis Policy Shift Tilray Brands eyes U.S. expansion as cannabis reclassification to Schedule III creates new opportunities for growth and clinical research.
benzinga.com What's Going On With SoFi Technologies Stock Thursday? SoFi Technologies faces volatility ahead of April 29 earnings. Read our technical breakdown, key support levels, and analyst consensus.